Symbols / IRON Stock $68.53 -1.69% Disc Medicine, Inc.
IRON (Stock) Chart
About
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. It also develops preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. The company was founded in 2017 and is headquartered in Watertown, Massachusetts.
Stock Fundamentals
Scroll to Statements| Market Cap | 2.62B | Enterprise Value | 1.90B | Income | -212.18M | Sales | — | Book/sh | 19.52 | Cash/sh | 20.73 |
| Dividend Yield | — | Payout | 0.00% | Employees | 155 | IPO | — | P/E | — | Forward P/E | -9.12 |
| PEG | — | P/S | — | P/B | 3.51 | P/C | — | EV/EBITDA | -8.09 | EV/Sales | — |
| Quick Ratio | 21.59 | Current Ratio | 21.94 | Debt/Eq | 4.19 | LT Debt/Eq | — | EPS (ttm) | -6.01 | EPS next Y | -7.52 |
| EPS Growth | — | Revenue Growth | — | Earnings | 2026-05-07 | ROA | -22.55% | ROE | -35.86% | ROIC | — |
| Gross Margin | 0.00% | Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 38.16M | Shs Float | 32.91M | Short Float | 15.79% |
| Short Ratio | 9.32 | Short Interest | — | 52W High | 99.50 | 52W Low | 40.00 | Beta | 2.54 | Avg Volume | 658.74K |
| Volume | 38.70K | Target Price | $100.17 | Recom | None | Prev Close | $69.71 | Price | $68.53 | Change | -1.69% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-02 | main | Wells Fargo | Overweight → Overweight | $79 |
| 2026-02-27 | main | Truist Securities | Buy → Buy | $83 |
| 2026-02-17 | main | Stifel | Buy → Buy | $110 |
| 2026-02-17 | main | Cantor Fitzgerald | Overweight → Overweight | $125 |
| 2026-02-17 | main | BMO Capital | Outperform → Outperform | $100 |
| 2026-02-17 | main | Wedbush | Outperform → Outperform | $88 |
| 2026-02-17 | main | Wells Fargo | Overweight → Overweight | $78 |
| 2025-12-16 | main | Wells Fargo | Overweight → Overweight | $109 |
| 2025-11-10 | main | Truist Securities | Buy → Buy | $114 |
| 2025-10-30 | main | Morgan Stanley | Overweight → Overweight | $115 |
| 2025-10-17 | main | Raymond James | Strong Buy → Strong Buy | $108 |
| 2025-10-17 | main | Cantor Fitzgerald | Overweight → Overweight | $153 |
| 2025-10-17 | main | Wedbush | Outperform → Outperform | $110 |
| 2025-08-18 | main | Morgan Stanley | Overweight → Overweight | $90 |
| 2025-07-21 | init | Truist Securities | — → Buy | $86 |
| 2025-07-03 | reit | HC Wainwright & Co. | Buy → Buy | $118 |
| 2025-06-17 | reit | HC Wainwright & Co. | Buy → Buy | $118 |
| 2025-05-12 | main | BMO Capital | Outperform → Outperform | $120 |
| 2025-03-18 | main | Cantor Fitzgerald | Overweight → Overweight | $132 |
| 2025-03-03 | main | Scotiabank | Sector Outperform → Sector Outperform | $75 |
- BHP stock holds at Sector Perform as RBC cites iron ore strength - Investing.com hu, 23 Apr 2026 07
- Myelofibrosis anemia data lands ASCO oral presentation on June 2 - Stock Titan ue, 21 Apr 2026 14
- Iron Mountain Stock Outlook: Is Wall Street Bullish or Bearish? - Yahoo Finance ue, 10 Feb 2026 08
- Best Iron Stocks of 2026 and How to Invest in Them - The Motley Fool Fri, 13 Mar 2026 07
- $IRON stock is down 14% today. Here's what we see in our data. - Quiver Quantitative Fri, 19 Dec 2025 08
- William Jacob Savage Sells 5,731 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat Wed, 15 Apr 2026 21
- Iron Horse Acquisitions II Corp. - Common Stock (Nasdaq:IRHO) Stock Quote - FinancialContent Mon, 20 Apr 2026 19
- Iron Mountain Inc. stock outperforms competitors on strong trading day - MarketWatch hu, 16 Apr 2026 20
- nLIGHT (LASR) Stock Iron Condor (Stalls) 2026-04-20 - Growth Investing - Cổng thông tin điện tử tỉnh Lào Cai Mon, 20 Apr 2026 15
- Iron Mountain Stock Up 19.5% in Three Months: Will the Trend Continue? - Zacks Investment Research hu, 09 Apr 2026 13
- What Makes Disc Medicine, Inc. (IRON) a Strong Momentum Stock: Buy Now? - Yahoo Finance Mon, 27 Oct 2025 07
- $IRON stock is down 8% today. Here's what we see in our data. - Quiver Quantitative hu, 15 Jan 2026 08
- Jean Franchi Sells 6,257 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat Wed, 15 Apr 2026 21
- Iron Mountain stock hits 52-week high at 115.31 USD - Investing.com hu, 16 Apr 2026 13
- Investors more bullish on Champion Iron (ASX:CIA) this week as stock grows 9.1%, despite earnings trending downwards over past five years - Yahoo Finance ue, 25 Nov 2025 08
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
236.02
+81.95%
|
129.72
+42.35%
|
91.12
+91.94%
|
47.48
|
| Research And Development |
|
170.64
+76.52%
|
96.67
+39.57%
|
69.26
+107.15%
|
33.44
|
| Selling General And Administration |
|
65.38
+97.83%
|
33.05
+51.18%
|
21.86
+55.73%
|
14.04
|
| General And Administrative Expense |
|
65.38
+97.83%
|
33.05
+51.18%
|
21.86
+55.73%
|
14.04
|
| Salaries And Wages |
|
36.84
+90.21%
|
19.37
+84.78%
|
10.48
|
—
|
| Other Gand A |
|
28.54
+108.62%
|
13.68
+20.23%
|
11.38
-18.93%
|
14.04
|
| Total Expenses |
|
236.02
+81.95%
|
129.72
+42.35%
|
91.12
+91.94%
|
47.48
|
| Operating Income |
|
-236.02
-81.95%
|
-129.72
-42.35%
|
-91.12
-91.94%
|
-47.48
|
| Total Operating Income As Reported |
|
-236.02
-81.95%
|
-129.72
-42.35%
|
-91.12
-91.94%
|
-47.48
|
| EBITDA |
|
-207.94
-92.05%
|
-108.27
-42.04%
|
-76.23
-60.87%
|
-47.39
|
| Normalized EBITDA |
|
-207.94
-92.05%
|
-108.27
-42.04%
|
-76.23
-61.08%
|
-47.33
|
| Reconciled Depreciation |
|
0.28
+80.13%
|
0.16
+56.00%
|
0.10
+12.36%
|
0.09
|
| EBIT |
|
-208.22
-92.03%
|
-108.43
-42.05%
|
-76.33
-60.78%
|
-47.48
|
| Total Unusual Items |
|
—
|
—
|
—
|
-0.06
|
| Total Unusual Items Excluding Goodwill |
|
—
|
—
|
—
|
-0.06
|
| Net Income |
|
-212.18
-94.03%
|
-109.36
-43.08%
|
-76.43
-63.22%
|
-46.83
|
| Pretax Income |
|
-211.82
-94.33%
|
-109.00
-42.80%
|
-76.33
-63.00%
|
-46.83
|
| Net Non Operating Interest Income Expense |
|
24.15
+16.57%
|
20.72
+40.03%
|
14.80
+1987.02%
|
0.71
|
| Interest Expense Non Operating |
|
3.61
+530.59%
|
0.57
|
0.00
|
—
|
| Net Interest Income |
|
24.15
+16.57%
|
20.72
+40.03%
|
14.80
+1987.02%
|
0.71
|
| Interest Expense |
|
3.61
+530.59%
|
0.57
|
0.00
|
—
|
| Interest Income Non Operating |
|
27.76
+30.38%
|
21.29
+43.89%
|
14.80
+1987.02%
|
0.71
|
| Interest Income |
|
27.76
+30.38%
|
21.29
+43.89%
|
14.80
+1987.02%
|
0.71
|
| Other Income Expense |
|
0.04
+2350.00%
|
-0.00
+0.00%
|
-0.00
+96.72%
|
-0.06
|
| Other Non Operating Income Expenses |
|
0.04
+2350.00%
|
-0.00
+0.00%
|
-0.00
|
—
|
| Gain On Sale Of Security |
|
—
|
—
|
—
|
-0.06
|
| Tax Provision |
|
0.36
+1.69%
|
0.35
+258.59%
|
0.10
|
0.00
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-212.18
-94.03%
|
-109.36
-43.08%
|
-76.43
-63.22%
|
-46.83
|
| Net Income From Continuing Operation Net Minority Interest |
|
-212.18
-94.03%
|
-109.36
-43.08%
|
-76.43
-63.22%
|
-46.83
|
| Net Income From Continuing And Discontinued Operation |
|
-212.18
-94.03%
|
-109.36
-43.08%
|
-76.43
-63.22%
|
-46.83
|
| Net Income Continuous Operations |
|
-212.18
-94.03%
|
-109.36
-43.08%
|
-76.43
-63.22%
|
-46.83
|
| Normalized Income |
|
-212.18
-94.03%
|
-109.36
-43.08%
|
-76.43
-63.43%
|
-46.77
|
| Net Income Common Stockholders |
|
-212.18
-94.03%
|
-109.36
-43.08%
|
-76.43
-63.22%
|
-46.83
|
| Diluted EPS |
|
—
|
-3.96
-15.79%
|
-3.42
+92.41%
|
-45.05
|
| Basic EPS |
|
—
|
-3.96
-15.79%
|
-3.42
+92.41%
|
-45.05
|
| Basic Average Shares |
|
—
|
27.61
+23.71%
|
22.32
+2046.81%
|
1.04
|
| Diluted Average Shares |
|
—
|
27.61
+23.71%
|
22.32
+2046.81%
|
1.04
|
| Diluted NI Availto Com Stockholders |
|
-212.18
-94.03%
|
-109.36
-43.08%
|
-76.43
-63.22%
|
-46.83
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
806.88
+62.42%
|
496.77
+34.99%
|
368.00
+83.81%
|
200.21
|
| Current Assets |
|
803.90
+62.86%
|
493.62
+34.99%
|
365.66
+84.22%
|
198.49
|
| Cash Cash Equivalents And Short Term Investments |
|
791.15
+61.50%
|
489.88
+35.93%
|
360.38
+85.18%
|
194.61
|
| Cash And Cash Equivalents |
|
91.14
-52.64%
|
192.43
-46.60%
|
360.38
+85.18%
|
194.61
|
| Other Short Term Investments |
|
700.01
+135.34%
|
297.45
|
0.00
|
—
|
| Prepaid Assets |
|
—
|
—
|
5.28
+36.08%
|
3.88
|
| Restricted Cash |
|
—
|
—
|
—
|
—
|
| Other Current Assets |
|
12.75
+241.35%
|
3.73
-29.28%
|
5.28
+36.08%
|
3.88
|
| Total Non Current Assets |
|
2.98
-5.60%
|
3.16
+35.30%
|
2.33
+36.17%
|
1.71
|
| Net PPE |
|
2.25
-2.80%
|
2.32
+10.48%
|
2.10
+31.41%
|
1.60
|
| Gross PPE |
|
2.25
-2.80%
|
2.32
-1.07%
|
2.35
+34.54%
|
1.74
|
| Accumulated Depreciation |
|
—
|
-0.40
-63.67%
|
-0.24
-68.97%
|
-0.14
|
| Properties |
|
—
|
0.00
|
0.00
|
—
|
| Machinery Furniture Equipment |
|
—
|
0.59
+41.20%
|
0.41
+32.59%
|
0.31
|
| Other Properties |
|
2.25
-2.80%
|
2.32
+20.21%
|
1.93
+34.97%
|
1.43
|
| Leases |
|
—
|
0.57
|
0.00
|
—
|
| Non Current Deferred Assets |
|
—
|
—
|
—
|
—
|
| Other Non Current Assets |
|
0.73
-13.37%
|
0.84
+258.12%
|
0.23
+101.72%
|
0.12
|
| Total Liabilities Net Minority Interest |
|
67.05
+26.07%
|
53.19
+132.51%
|
22.88
-3.09%
|
23.61
|
| Current Liabilities |
|
36.64
+57.15%
|
23.32
+8.76%
|
21.44
-5.04%
|
22.58
|
| Payables And Accrued Expenses |
|
23.39
+46.40%
|
15.97
+6.61%
|
14.98
-19.65%
|
18.65
|
| Payables |
|
9.02
+13.46%
|
7.95
-37.07%
|
12.63
-21.86%
|
16.16
|
| Accounts Payable |
|
9.02
+13.46%
|
7.95
-37.07%
|
12.63
-21.86%
|
16.16
|
| Current Accrued Expenses |
|
14.37
+79.02%
|
8.03
+240.85%
|
2.35
-5.27%
|
2.49
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
12.64
+75.32%
|
7.21
+24.54%
|
5.79
+59.81%
|
3.62
|
| Current Debt And Capital Lease Obligation |
|
0.61
+370.00%
|
0.13
-80.45%
|
0.67
+116.61%
|
0.31
|
| Current Debt |
|
—
|
—
|
—
|
—
|
| Other Current Borrowings |
|
—
|
—
|
—
|
—
|
| Current Capital Lease Obligation |
|
0.61
+370.00%
|
0.13
-80.45%
|
0.67
+116.61%
|
0.31
|
| Other Current Liabilities |
|
—
|
—
|
—
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
30.41
+1.81%
|
29.87
+1980.08%
|
1.44
+39.82%
|
1.03
|
| Long Term Debt And Capital Lease Obligation |
|
30.41
+1.81%
|
29.87
+1980.08%
|
1.44
+39.82%
|
1.03
|
| Long Term Debt |
|
29.16
+2.96%
|
28.32
|
—
|
—
|
| Long Term Capital Lease Obligation |
|
1.25
-19.06%
|
1.55
+7.80%
|
1.44
+39.82%
|
1.03
|
| Other Non Current Liabilities |
|
—
|
—
|
—
|
—
|
| Preferred Securities Outside Stock Equity |
|
—
|
—
|
—
|
0.00
|
| Stockholders Equity |
|
739.83
+66.78%
|
443.59
+28.53%
|
345.12
+95.43%
|
176.60
|
| Common Stock Equity |
|
739.83
+66.78%
|
443.59
+28.53%
|
345.12
+95.43%
|
176.60
|
| Capital Stock |
|
0.00
+33.33%
|
0.00
+50.00%
|
0.00
+0.00%
|
0.00
|
| Common Stock |
|
0.00
+33.33%
|
0.00
+50.00%
|
0.00
+0.00%
|
0.00
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
37.89
+26.87%
|
29.87
+22.60%
|
24.36
+39.97%
|
17.40
|
| Ordinary Shares Number |
|
37.89
+26.87%
|
29.87
+22.60%
|
24.36
+39.97%
|
17.40
|
| Additional Paid In Capital |
|
1,249.04
+68.49%
|
741.30
+38.88%
|
533.76
+84.81%
|
288.81
|
| Retained Earnings |
|
-510.19
-71.20%
|
-298.00
-57.97%
|
-188.65
-68.11%
|
-112.22
|
| Gains Losses Not Affecting Retained Earnings |
|
0.96
+233.91%
|
0.29
|
0.00
|
—
|
| Other Equity Adjustments |
|
0.96
+233.91%
|
0.29
|
—
|
—
|
| Total Equity Gross Minority Interest |
|
739.83
+66.78%
|
443.59
+28.53%
|
345.12
+95.43%
|
176.60
|
| Total Capitalization |
|
768.99
+62.95%
|
471.91
+36.74%
|
345.12
+95.43%
|
176.60
|
| Working Capital |
|
767.26
+63.14%
|
470.30
+36.63%
|
344.22
+95.68%
|
175.91
|
| Invested Capital |
|
768.99
+62.95%
|
471.91
+36.74%
|
345.12
+95.43%
|
176.60
|
| Total Debt |
|
31.02
+3.41%
|
30.00
+1327.89%
|
2.10
+57.50%
|
1.33
|
| Capital Lease Obligations |
|
1.86
+11.08%
|
1.68
-20.13%
|
2.10
+57.50%
|
1.33
|
| Net Tangible Assets |
|
739.83
+66.78%
|
443.59
+28.53%
|
345.12
+95.43%
|
176.60
|
| Tangible Book Value |
|
739.83
+66.78%
|
443.59
+28.53%
|
345.12
+95.43%
|
176.60
|
| Derivative Product Liabilities |
|
—
|
—
|
—
|
—
|
| Interest Payable |
|
—
|
—
|
—
|
—
|
| Preferred Stock Equity |
|
—
|
—
|
—
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-180.39
-92.06%
|
-93.93
-27.86%
|
-73.46
-73.87%
|
-42.25
|
| Cash Flow From Continuing Operating Activities |
|
-180.39
-92.06%
|
-93.93
-27.86%
|
-73.46
-73.87%
|
-42.25
|
| Net Income From Continuing Operations |
|
-212.18
-94.03%
|
-109.36
-43.08%
|
-76.43
-63.22%
|
-46.83
|
| Depreciation Amortization Depletion |
|
0.28
+80.13%
|
0.16
+56.00%
|
0.10
+12.36%
|
0.09
|
| Depreciation |
|
—
|
—
|
—
|
—
|
| Depreciation And Amortization |
|
0.28
+80.13%
|
0.16
+56.00%
|
0.10
+12.36%
|
0.09
|
| Other Non Cash Items |
|
2.16
+305.82%
|
0.53
+83.79%
|
0.29
+37.44%
|
0.21
|
| Stock Based Compensation |
|
34.34
+104.22%
|
16.82
+204.07%
|
5.53
+164.72%
|
2.09
|
| Operating Gains Losses |
|
—
|
—
|
—
|
0.06
|
| Gain Loss On Investment Securities |
|
—
|
—
|
—
|
0.06
|
| Gain Loss On Sale Of PPE |
|
—
|
—
|
—
|
—
|
| Change In Working Capital |
|
3.53
+9.13%
|
3.23
+209.41%
|
-2.95
-238.96%
|
2.12
|
| Change In Prepaid Assets |
|
-8.92
-667.92%
|
1.57
+234.73%
|
-1.17
-431.25%
|
0.35
|
| Change In Payables And Accrued Expense |
|
12.26
+469.00%
|
2.15
+224.35%
|
-1.73
-185.45%
|
2.03
|
| Change In Accrued Expense |
|
11.19
+63.72%
|
6.84
+240.44%
|
2.01
+33.69%
|
1.50
|
| Change In Payable |
|
1.07
+122.86%
|
-4.68
-25.13%
|
-3.74
-811.22%
|
0.53
|
| Change In Account Payable |
|
1.07
+122.86%
|
-4.68
-25.13%
|
-3.74
-811.22%
|
0.53
|
| Change In Other Working Capital |
|
—
|
—
|
—
|
—
|
| Change In Other Current Assets |
|
—
|
—
|
0.00
-100.00%
|
0.06
|
| Change In Other Current Liabilities |
|
0.19
+137.58%
|
-0.49
-816.67%
|
-0.05
+83.07%
|
-0.32
|
| Investing Cash Flow |
|
-394.30
-34.88%
|
-292.33
-328362.92%
|
-0.09
+41.06%
|
-0.15
|
| Cash Flow From Continuing Investing Activities |
|
-394.30
-34.88%
|
-292.33
-328362.92%
|
-0.09
+41.06%
|
-0.15
|
| Net PPE Purchase And Sale |
|
-0.93
-84.75%
|
-0.51
-467.42%
|
-0.09
+41.06%
|
-0.15
|
| Purchase Of PPE |
|
-0.93
-84.75%
|
-0.51
-467.42%
|
-0.09
+41.06%
|
-0.15
|
| Sale Of PPE |
|
—
|
—
|
—
|
—
|
| Capital Expenditure |
|
-0.93
-84.75%
|
-0.51
-467.42%
|
-0.09
+41.06%
|
-0.15
|
| Net Investment Purchase And Sale |
|
-393.37
-34.79%
|
-291.83
|
0.00
|
—
|
| Purchase Of Investment |
|
-849.59
-119.74%
|
-386.63
|
0.00
|
—
|
| Sale Of Investment |
|
456.22
+381.24%
|
94.80
|
0.00
|
—
|
| Financing Cash Flow |
|
473.41
+116.85%
|
218.31
-8.80%
|
239.38
+60.68%
|
148.98
|
| Cash Flow From Continuing Financing Activities |
|
473.41
+116.85%
|
218.31
-8.80%
|
239.38
+60.68%
|
148.98
|
| Net Issuance Payments Of Debt |
|
0.00
-100.00%
|
28.99
|
0.00
|
—
|
| Issuance Of Debt |
|
0.00
-100.00%
|
28.99
|
0.00
|
—
|
| Repayment Of Debt |
|
—
|
—
|
—
|
—
|
| Long Term Debt Issuance |
|
0.00
-100.00%
|
28.99
|
0.00
|
—
|
| Long Term Debt Payments |
|
—
|
—
|
—
|
—
|
| Net Long Term Debt Issuance |
|
0.00
-100.00%
|
28.99
|
0.00
|
—
|
| Net Common Stock Issuance |
|
450.11
+140.31%
|
187.30
-5.92%
|
199.08
+272.11%
|
53.50
|
| Proceeds From Stock Option Exercised |
|
23.30
+581.74%
|
3.42
-91.52%
|
40.30
+18302.28%
|
0.22
|
| Net Other Financing Charges |
|
—
|
-1.39
|
—
|
95.26
|
| Changes In Cash |
|
-101.28
+39.69%
|
-167.94
-201.28%
|
165.83
+55.60%
|
106.58
|
| Beginning Cash Position |
|
192.67
-46.57%
|
360.62
+85.13%
|
194.79
+120.82%
|
88.21
|
| End Cash Position |
|
91.39
-52.57%
|
192.67
-46.57%
|
360.62
+85.13%
|
194.79
|
| Free Cash Flow |
|
-181.33
-92.02%
|
-94.43
-28.39%
|
-73.55
-73.46%
|
-42.40
|
| Interest Paid Supplemental Data |
|
2.79
+1311.62%
|
0.20
|
0.00
|
—
|
| Income Tax Paid Supplemental Data |
|
—
|
0.30
+166.96%
|
0.11
|
0.00
|
| Amortization Of Securities |
|
-8.52
-60.61%
|
-5.30
|
0.00
|
—
|
| Common Stock Issuance |
|
450.11
+140.31%
|
187.30
-5.92%
|
199.08
+272.11%
|
53.50
|
| Issuance Of Capital Stock |
|
450.11
+140.31%
|
187.30
-5.92%
|
199.08
+272.11%
|
53.50
|
| Net Preferred Stock Issuance |
|
—
|
—
|
—
|
0.00
|
| Preferred Stock Issuance |
|
—
|
—
|
—
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-15 View
- 42026-04-15 View
- 42026-03-04 View
- 42026-02-27 View
- 8-K2026-02-27 View
- 10-K2026-02-26 View
- 8-K2026-02-26 View
- 42026-02-19 View
- 42026-02-17 View
- 42026-02-17 View
- 42026-02-17 View
- 42026-02-17 View
- 42026-02-17 View
- 8-K2026-02-17 View
- 8-K2026-02-13 View
- 42026-02-11 View
- 42026-02-11 View
- 42026-02-11 View
- 42026-02-11 View
- 42026-02-11 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|